Demoralization in Parkinson disease
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To determine the prevalence and associated features of demoralization in Parkinson disease (PD).
Methods Participants with PD and controls were prospectively recruited from outpatient movement disorder clinics and the community. Demoralization was defined as scoring positively on the Diagnostic Criteria for Psychosomatic Research, Demoralization questionnaire or Kissane Demoralization Scale score ≥24. Depression was defined as Patient Health Questionnaire-9 score ≥10. Forward stepwise logistic regression was used to determine the odds of having demoralization in the overall, control, and PD cohorts.
Results Demoralization occurred in 18.1% of 94 participants with PD and 8.1% of 86 control participants (p = 0.05). These 2 groups were otherwise comparable in age, sex, education, economics, race, and marital status. Although demoralization was highly associated with depression, there were individuals with one and not the other. Among participants with PD, 7 of 19 (36.8%) depressed individuals were not demoralized, and 5 of 17 (29.4%) demoralized individuals were not depressed. In the overall cohort, having PD (odds ratio 2.60, 95% confidence interval 1.00–6.80, p = 0.051) was associated with demoralization, along with younger age and not currently being married. In the PD cohort, younger age and Unified Parkinson's Disease Rating Scale, part III score (per score 1) were associated with demoralization (odds ratio 1.06, 95% confidence interval 1.01–1.12, p = 0.02).
Conclusions Demoralization is common in PD and is associated with motor dysfunction. In demoralization, there is a prominent inability to cope, making it somewhat distinct from depression. Treatment approaches are also different, making it important to identify demoralization in patients with PD.
Glossary
- DCPR-D=
- Diagnostic Criteria for Psychosomatic Research, Demoralization;
- DSM=
- Diagnostic and Statistical Manual of Mental Disorders;
- KDS=
- Kissane Demoralization Scale;
- PHQ9=
- Patient Health Questionnaire-9;
- UPDSR-m=
- Unified Parkinson's Disease Rating Scale, part III
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received November 13, 2017.
- Accepted in final form February 12, 2018.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Response to Dr. Bruno comment on Demoralization in PD
- Brian B. Koo, Neurologist, Yale University
Submitted May 25, 2018 - Reader response: Demoralization in Parkinson disease
- Veronica Bruno, MD, Neurologist, University of Calgary, Department of Clinical Neurosciences
- Deborah Mancini, Research coordinator, Toronto Western Hospital, University of Toronto
- Mateusz Zurowski, MD, Psychiatrist, Toronto Western Hospital, University of Toronto
- Janis M Miyasaki, MD, Neurologist, University of Alberta
Submitted April 23, 2018
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
The influence of depression on cognition in Parkinson's diseaseA pattern of impairment distinguishable from Alzheimer's diseaseA. I. Troster, A. M. Paolo, K. E. Lyons et al.Neurology, April 01, 1995 -
Articles
Imaging amyloid deposition in Lewy body diseasesS. N. Gomperts, D. M. Rentz, E. Moran et al.Neurology, September 15, 2008 -
Articles
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PETH. Shimada, S. Hirano, H. Shinotoh et al.Neurology, May 27, 2009 -
Articles
Driving with distraction in Parkinson diseaseE. Y. Uc, M. Rizzo, S. W. Anderson et al.Neurology, November 27, 2006